{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:17:46Z","timestamp":1770913066704,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04785-5","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:16:55Z","timestamp":1770124615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C3 glomerulonephritis with light chain crystalline podocytopathy and non-crystalline proximal tubulopathy: a case report and integrative clinicopathologic analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Jingzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingmin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"4785_CR1","doi-asserted-by":"crossref","unstructured":"Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019;15(1):45-59.","DOI":"10.1038\/s41581-018-0077-4"},{"key":"4785_CR2","doi-asserted-by":"crossref","unstructured":"Li LL, Li ZY, Wang SX, Yu XJ, Tan Y, Wang Y, et al. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis. BMC Nephrol. 2019;20(1):459.","DOI":"10.1186\/s12882-019-1640-3"},{"key":"4785_CR3","doi-asserted-by":"crossref","unstructured":"Ruiz-Fuentes MC, Caba-Molina M, Polo-Moyano A, Palomares-Bayo M, Galindo-Sacristan P, De Gracia-Guindo C. A 78-year-old man with chronic kidney disease and monoclonal gammopathy who developed post-transplant C3 glomerulopathy - recurrence or de novo? A case report and literature Review. Am J Case Rep. 2023;24:e939726.","DOI":"10.12659\/AJCR.939726"},{"key":"4785_CR4","doi-asserted-by":"crossref","unstructured":"Nasr SH, Sirac C, Leung N, Bridoux F. Monoclonal immunoglobulin crystalline nephropathies. Kidney Int. 2024;106(2):201\u201313.","DOI":"10.1016\/j.kint.2024.02.027"},{"key":"4785_CR5","doi-asserted-by":"crossref","unstructured":"Sethi S, Rajkumar SV, D\u2019Agati VD. The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Soc Nephrol. 2018;29(7):1810\u201323.","DOI":"10.1681\/ASN.2017121319"},{"key":"4785_CR6","doi-asserted-by":"crossref","unstructured":"Smith R, Appel GB, Blom AM, Cook HT, D\u2019Agati VD, Fakhouri F, et al. C3 glomerulopathy - understanding a rare complement-driven renal disease. Nat Rev Nephrol. 2019;15(3):129\u201343.","DOI":"10.1038\/s41581-018-0107-2"},{"key":"4785_CR7","doi-asserted-by":"crossref","unstructured":"Johnson CK, Zuniga SC, Dhawale T, Zhang Y, Smith R, Blosser CD. Monoclonal gammopathy of renal significance causes C3 glomerulonephritis via monoclonal IgG kappa inhibition of complement factor H. Kidney Int Rep. 2021;6(9):2505\u20139.","DOI":"10.1016\/j.ekir.2021.06.015"},{"key":"4785_CR8","doi-asserted-by":"crossref","unstructured":"Chauvet S, Roumenina LT, Aucouturier P, Marinozzi MC, Dragon-Durey MA, Karras A, et al. Both monoclonal and polyclonal Immunoglobulin contingents mediate complement activation in monoclonal gammopathy associated-C3 glomerulopathy. Front Immunol. 2018;9:2260.","DOI":"10.3389\/fimmu.2018.02260"},{"key":"4785_CR9","doi-asserted-by":"crossref","unstructured":"Ribas A, Puche A, Gimeno J, Sans L, Barrios C, Marquez E, et al. Podocytopathy in patients with monoclonal gammopathy: three patients and literature review. Clin Kidney J. 2022;15(3):417\u201324.","DOI":"10.1093\/ckj\/sfab176"},{"issue":"1108","key":"4785_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.kint.2025.04.007","volume":"2025\/8","author":"SH Nasr","year":"2025","unstructured":"Nasr SH, Royal V, Best Rocha A, B\u00fcttner-Herold M, Roufosse C, Bridoux F, et al. Renal Pathology Society\/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions. Kidney Int. 2025;108(2):184\u201393.","journal-title":"KIDNEY INT"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04785-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:27:24Z","timestamp":1770910044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04785-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4785"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04785-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the Ethics Committee of Ningbo Yinzhou No 2 Hospital (Approval No: 2025-008) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from the individual participant included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the participant involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}